Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain MDCO message board posts where the ticker symbol MDCO has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest MDCO SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001182489-18-000383 Size: 6 KB
2018-09-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001182489-18-000381 Size: 6 KB
2018-09-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001182489-18-000378 Size: 4 KB
2018-09-05
8-K  Documents Current report, item 5.02
Acc-no: 0001113481-18-000043 (34 Act)  Size: 21 KB
2018-08-28 000-31191
181042193
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-007491 (34 Act)  Size: 11 KB
2018-08-27 000-31191
181039558
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001179110-18-010174 Size: 4 KB
2018-08-02
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001113481-18-000041 (34 Act)  Size: 7 MB
2018-08-02 000-31191
18986855
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001113481-18-000039 (34 Act)  Size: 278 KB
2018-08-01 000-31191
18983101
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001179110-18-009496 Size: 4 KB
2018-07-05
SC 13G  Documents Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001341004-18-000343 (34 Act)  Size: 129 KB
2018-06-11 005-60201
18892102
More MDCO SEC Filings


Related news from
Mon, 15 Oct 2018
13:10:00 +0000
Investor Expectations to Drive Momentum within Fossil Group, The Medicines, BWX Technologies, PVH, Group 1 Automotive, and Assurant — Discovering Underlying Factors of Influence
NEW YORK, Oct. 15, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Thu, 04 Oct 2018
02:20:31 +0000
[$$] Drugs regulator warns on no-deal Brexit access to new medicines
, the UK drugs regulator has warned. without a deal, the Medicines and Healthcare products Regulatory Agency also acknowledged there would be “costs” to business as it coped with additional regulatory hurdles to sell products in the UK. As the UK would become a standalone regulator, only medicines approved by the MHRA would be able to reach the UK market, it says.
Wed, 03 Oct 2018
15:37:03 +0000
Medicines Company to Continue Inclisiran Studies as Planned
The Medicines Company (MDCO) gets Independent Data Monitoring Committee's recommendation to continue late-stage inclisiran studies as planned and designed.
Mon, 01 Oct 2018
11:00:00 +0000
The Medicines Company Announces Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase III Trials Following Fourth Review of Unblinded Data
The Medicines Company (MDCO) today announced that the Independent Data Monitoring Committee (IDMC) for the ongoing inclisiran Phase III trials has recommended that the trials continue as designed and conducted, without modification. The IDMC’s recommendation was based on its planned review of unblinded safety and efficacy data from the trials. The ORION Phase III studies with 18-months follow up were fully enrolled between November 2017 and March 2018, with 3,660 patients randomized 1:1 across three trials – ORION-9 (482 patients randomized), ORION-10 (1,561 patients randomized) and ORION-11 (1,617 patients randomized) – to receive either inclisiran or placebo.
Thu, 20 Sep 2018
12:06:16 +0000
See what the IHS Markit Score report has to say about Medicines Co.
Medicines Co NASDAQ/NGS:MDCO
Mon, 17 Sep 2018
12:51:12 +0000
Are Options Traders Betting on a Big Move in Medicines Company (MDCO) Stock?
Investors need to pay close attention to Medicines Company (MDCO) stock based on the movements in the options market lately.
Thu, 06 Sep 2018
21:34:45 +0000
5 Stocks With Low Price-Sales Ratios
According to the GuruFocus All-in-One Screener, the following stocks with market caps over $5 billion look cheap since they are trading with low price-sales ratios. Olin Corp. (OLN) is trading around $30.27 with a price-sales ratio of 0.8, a price-earnings ratio of 8.2 and a forward price-earnings ratio of 11.6. The company has a market cap of $5.06 billion and the stock price has risen at an annualized rate of 5% over the last 10 years.
Fri, 31 Aug 2018
14:24:02 +0000
Why Is Medicines Co. (MDCO) Up 2.7% Since Last Earnings Report?
Medicines Co. (MDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tue, 14 Aug 2018
19:40:17 +0000
Edited Transcript of MDCO earnings conference call or presentation 1-Aug-18 12:30pm GMT
Q2 2018 Medicines Co Earnings Call
Tue, 14 Aug 2018
12:30:00 +0000
Report: Exploring Fundamental Drivers Behind EnLink Midstream, CENTENNIAL RES, Mondelez International, Pacific Premier, Farmland Partners, and The Medicines — New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Aug. 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of EnLink ...
Fri, 10 Aug 2018
14:31:19 +0000
What Alnylam Pharmaceuticals’ Bottom Line Trend Indicates
Alnylam Pharmaceuticals’ (ALNY) interest income increased from $2.58 million in the second quarter of 2017 to $6.1 million in the second quarter of 2018.
Thu, 02 Aug 2018
16:00:04 +0000
Medicines Company (MDCO) Q2 Loss Narrows, Revenues Tank Y/Y
The Medicines Company (MDCO) beats earnings estimates while missing the same for revenues in the second quarter.
Wed, 01 Aug 2018
13:15:01 +0000
Medicines Co. (MDCO) Reports Q2 Loss, Misses Revenue Estimates
Medicines Co. (MDCO) delivered earnings and revenue surprises of 1.56% and -78.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum has been the most valuable tool I have ever come across when it comes to managing my investments. I can honestly say that the information shared on ValueForum has led me to retire earlier than expected. This is a wonderful investment site, period." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards